Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Krystal Biotech's gene therapy Vyjuvek gains European approval, expanding treatment options for rare skin disease dystrophic ...

Biotechnology company Amgen announced a $900 million manufacturing expansion in Ohio on Friday, bringing 350 new jobs to ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...

Revvity reported first-quarter results above Wall Street estimates and maintained its full-year profit forecast on Monday, ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

Krystal Biotech, a biotechnology firm based in Pittsburgh, is dedicated to developing genetic treatments for unmet medical needs and has successfully launched VYJUVEK®, the first FDA-approved ...